Results 261 to 270 of about 944,610 (376)

Exploring the Antiviral Potential of Tungsten Oxide Nanoparticles Against Herpes Simplex Virus Type 1: A Promising Alternative to Acyclovir

open access: yesIET Nanobiotechnology, Volume 2026, Issue 1, 2026.
Herpes simplex virus type 1 (HSV‐1) is responsible for the majority of cold sores, herpetic keratitis‐induced blindness, profound skin lesions, and encephalitis that can be fatal. Currently, acyclovir and its derivatives are the first‐line therapy for the treatment of HSV‐1 infection.
Abdulhussain Kadhim Jwaziri   +7 more
wiley   +1 more source

An epidemiological analysis of hospitalizations due to viral encephalitis in Ceará from 2013-2023

open access: gold
María Cristina Marcucci   +8 more
openalex   +1 more source

Viral Encephalitis and Neurologic Diseases: Focus on Astrocytes.

open access: yesTrends in Molecular Medicine, 2018
A. Soung, R. Klein
semanticscholar   +1 more source

Neurofilament light chain as a marker of peripheral nerve damage in vasculitic neuropathy? A cross‐compartmental correlation analysis in patients undergoing nerve biopsy

open access: yesBrain Pathology, Volume 36, Issue 1, January 2026.
To assess neurofilament light chain (NfL) as a biomarker of peripheral nerve damage, we correlated serumNfL concentrations with histopathological parameters from matched sural nerve biopsies. SerumNfL levels correlated with markers of acute axonal degeneration, but not with parameters reflecting chronic axonal loss.
Simon Streit   +10 more
wiley   +1 more source

Herpes simplex virus-1 evasion of CD8+ T cell accumulation contributes to viral encephalitis.

open access: yesJournal of Clinical Investigation, 2017
Naoto Koyanagi   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy